- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04669483
Development, Piloting and Evaluation of an Evidence-based Informed Consent Form for Total Knee Arthroplasty (EvAb-Pilot)
Every medical intervention requires informed consent. Informed consent may include comprehensible information about the necessity and kind of the intervention, material risks and consequences or alternative treatments. Practitioners frequently use consent forms to support the physician-patient conversation and to document informed consent. Studies show, that informed consent forms used in practice, are heterogeneous.
This study aims at investigating the effects of evidence-based informed consent forms for Total Knee Replacement and related anaesthesia procedures.
Evidence-based informed consent forms include best and latest evidence in lay language. It is hypothesized that evidence-based informed consent forms - compared to standard consent forms - improve patients' risk perception, reduce anxiety of complications and reduce the nocebo effect (unspecific negative effects caused by the way of communicating risks).
To compare evidence-based and standard informed consent forms, an Interrupted Time Series pilot study will be conducted. It is planned to include 220 patients, who are scheduled for elective total knee replacement surgery.
The accompanying qualitative analyses ensure that the (German) legal requirements for informed consent are met.
Study Overview
Status
Intervention / Treatment
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Contact
- Name: Alina Weise, M. Sc.
- Phone Number: +49 221/9895741
- Email: Alina.Weise@uni-wh.de
Study Locations
-
-
NRW
-
Cologne, NRW, Germany, 51109
- Recruiting
- Cologne Merheim Medical Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patients are scheduled for an elective total knee arthroplasty surgery
- Patients are at least 18 years old
- Patients are able to understand and speak German
- Patients are mentally competent to give consent and answer questions
Exclusion Criteria:
- Patients with revision
- Patients with posttraumatic arthrosis
Study Plan
How is the study designed?
Design Details
- Observational Models: Other
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Intervention group (post-interruption)
Patients receive evidence-based informed consent forms for total knee arthroplasty and related anaesthesia procedures
|
Evidence-based informed consent forms for total knee arthroplasty and related anesthesia procedures will be developed.
The design of the evidence-based informed consent forms will be guided by an existing guideline on how to present evidence-based health information (guideline evidence-based health information) and nocebo research.
The information will be presented in plain language.
Benefits and harms of the procedures will be presented in absolute risk formats and in comparison with other interventions or placebo.
Verbal presentations of risks lead to overestimations of risks and therefore, will not be applied exclusively.
Gain and loss framing will be combined.
To visualize important aspects, pictograms will be used.
Information on uncertainty, missing or low quality evidence will be provided.
|
Control group (pre-interruption)
Patients receive standard consent forms (of the study centre) for total knee arthroplasty and related anaesthesia procedures
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Anxiety: Change from baseline anxiety after the informed consent procedure assessed by the surgical fear questionnaire and a numeric rating scale (0-10)
Time Frame: Anxiety will be measured at the day of consultation - approximately 4 weeks before surgery - (baseline) and one day before surgery
|
The surgical fear questionnaire is a validated questionnaire for measuring patient reported fear of surgery.
The questionnaire includes the following items: fear of operation, fear of anaesthesia, postoperative pain, side effects, health deterioration, failed operation, incomplete recovery, long duration of rehabilitation.
|
Anxiety will be measured at the day of consultation - approximately 4 weeks before surgery - (baseline) and one day before surgery
|
Nocebo-Effect: Proportion of patients with patient reported adverse events/complications and cummulaive number of adverse events/complications assessed by closed and open questions
Time Frame: approximately three days after hospital discharge
|
The occurence of specific adverse events/complications (e.g.
postoperative nausea and vomitting) will be queried.
In addition it will be queried whether other adverse events/ complications not mentioned before have occurred.
|
approximately three days after hospital discharge
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Knowledge/risk perception: Proportion of correctly answered questions assessed by knowledge questions about benefits and risks of undergoing surgery
Time Frame: One day before surgery
|
The objective knowledge questions (e.g.
correct risk assessment) will be derived when developing the evidence-based informed consent forms.
The development will be based on previous experiences with the measure of informed choice.
|
One day before surgery
|
Mean satisfaction with the physician-patient-communication and informed consent form assessed by a numeric rating scale (0-10)
Time Frame: One day before surgery
|
Patients will be queried about their overall satisfaction with the physician-patient-communication and with the informed consent form using a numeric rating scale (0-10)
|
One day before surgery
|
Mean Quality of life (QoL) assessed by a numeric rating scale (0-10)
Time Frame: approximately one month after hospital discharge
|
Patients will be queried about their current overall quality of life assessed by a numeric rating scale (0-10)
|
approximately one month after hospital discharge
|
Mean pain and function of the knee assessed by the Oxford Knee Score
Time Frame: approximately one month after hospital discharge
|
The Oxford Knee Score (OKS) is a validated patient reported outcome measure for patients undergoing total knee arthroplasty, that consists of 12 questions about the individual's activities of daily live and how they have been affected by pain over the preceding four weeks.
|
approximately one month after hospital discharge
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Tim Mathes, Dr., Institute for Research in Operative Medicine (IFOM), Witten/Herdecke University
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- EvAb-P-V1
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Osteoarthritis, Knee
-
LifeBridge HealthMicroPort Orthopedics Inc.; Rubin Institute for Advanced OrthopedicsRecruitingKnee Osteoarthritis | Osteoarthritis, Knee | Knee Pain Chronic | Arthropathy of Knee Joint | Knee Disease | Osteoarthritis Knees Both | Osteoarthritis Knee Left | Osteoarthritis Knee RightUnited States
-
University Hospital, Clermont-FerrandSanofiCompletedKnee Osteoarthritis (Knee OA)France
-
Joseph E. BroylesCompletedDegenerative Lesion of Articular Cartilage of Knee | Degeneration; Articular Cartilage, Knee | Unilateral Primary Osteoarthritis of Knee | Osteoarthritis Knee
-
Jiangsu XinChen-Techfields Pharma Co., LTD.Completed
-
The Hong Kong Polytechnic UniversityCompleted
-
Federal University of São PauloCompletedKNEE OSTEOARTHRITISBrazil
-
Novartis PharmaceuticalsRecruitingSymptomatic Knee OsteoarthritisUnited States, Spain, Hungary, Argentina, Germany, Slovakia, Czechia, Belgium, Romania
-
University of BathUniversity of Oxford; 3D Metal Printing Ltd; Versus ArthritisRecruitingMedial Knee OsteoarthritisUnited Kingdom
-
Max Biocare Pty. Ltd.Completed
Clinical Trials on evidence-based informed consent form
-
Carnegie Mellon UniversityICON plcCompletedConsent Forms
-
Kantonsspital Winterthur KSWRecruiting
-
Centro Hospitalar Tondela-ViseuCompletedGastrointestinal Endoscopy | Informed ConsentPortugal
-
University of California, DavisCompleted
-
Emory UniversityCompleted
-
Carnegie Mellon UniversityICON plcCompletedAsthma | Consent FormsUnited States
-
Seoul National University HospitalCompletedLumbar RadiculopathyKorea, Republic of
-
Changhai HospitalUnknown
-
Ankara UniversityCompleted
-
Mayo ClinicActive, not recruitingCancerUnited States